Literature DB >> 12489982

Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats.

Danny M Hasselbaink1, Jan F C Glatz, Joost J F P Luiken, Theo H M Roemen, Ger J Van der Vusse.   

Abstract

According to the current paradigm, fatty acid (FA) utilization is increased in the diabetic heart. Since plasma levels of competing substrates such as ketone bodies are increased during diabetes, the effect of those substrates on cardiac FA handling was explored. Cardiomyocytes were isolated from control and streptozotocin-treated diabetic rats and incubated with normal (80 microM) and elevated (160 microM) palmitate concentrations in the absence or presence of ketone bodies, including acetoacetate (AcAc). Comparing control cardiomyocytes under normal conditions (80 microM, no AcAc) with diabetic cardiomyocytes (160 microM, 3 mM AcAc) showed that palmitate uptake was increased from 35.2 +/- 4.8 to 60.2 +/- 14.0 nmol x 3 min(-1) x g wet weight(-1) respectively. Under these conditions, palmitate oxidation rates were comparable (58.9 +/- 23.6 versus 53.2 +/- 18.5 nmol x 30 min(-1) x g wet weight(-1)). However, in the absence of AcAc, palmitate oxidation was significantly enhanced in diabetic cardiomyocytes, indicating that ketone bodies are able to suppress cardiac FA oxidation in diabetes. The concomitantly increased FA uptake in diabetic cells, mainly due to the elevated extracellular FA levels, may be responsible for the accumulation of FA and triacylglycerol, as observed in the diabetic heart in situ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12489982      PMCID: PMC1223317          DOI: 10.1042/BJ20021617

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

Review 1.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes.

Authors:  L Laffel
Journal:  Diabetes Metab Res Rev       Date:  1999 Nov-Dec       Impact factor: 4.876

Review 2.  Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.

Authors:  N Latruffe; J Vamecq
Journal:  Biochimie       Date:  1997 Feb-Mar       Impact factor: 4.079

3.  Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells.

Authors:  X Wang; A J Levi; A P Halestrap
Journal:  Am J Physiol       Date:  1996-02

4.  Effects of ischemia on rat myocardial function and metabolism in diabetes.

Authors:  D Feuvray; J A Idell-Wenger; J R Neely
Journal:  Circ Res       Date:  1979-03       Impact factor: 17.367

5.  Characteristics of the myocardial PM-FABP: effect of diabetes mellitus.

Authors:  C E Heyliger; A L Scarim; V P Eymer; K A Skau; D M Powell
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 6.  Genetics of energetics: transcriptional responses in cardiac metabolism.

Authors:  H Taegtmeyer
Journal:  Ann Biomed Eng       Date:  2000-08       Impact factor: 3.934

7.  Influence of exogenous fatty acids and ketone bodies on rates of lipolysis in isolated ventricular myocytes from normal and diabetic rats.

Authors:  T S Larsen; D L Severson
Journal:  Can J Physiol Pharmacol       Date:  1990-09       Impact factor: 2.273

8.  Relationship between plasma and muscle concentrations of ketone bodies and free fatty acids in fed, starved and alloxan-diabetic states.

Authors:  O E Owen; H Markus; S Sarshik; M Mozzoli
Journal:  Biochem J       Date:  1973-06       Impact factor: 3.857

9.  A comparison of fatty acid patterns of arterial plasma, pericardial fluid and cardiac lymph in dog.

Authors:  P Julien; L Gailis; M Lepage; P E Roy
Journal:  Artery       Date:  1979-01

10.  Possible mechanisms responsible for the rise in plasma vasopressin associated with diabetic ketoacidosis in the rat.

Authors:  J A Charlton; C J Thompson; P H Baylis
Journal:  J Endocrinol       Date:  1988-03       Impact factor: 4.286

View more
  16 in total

1.  Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.

Authors:  Mariane Abdillahi; Radha Ananthakrishnan; Srinivasan Vedantham; Linshan Shang; Zhengbin Zhu; Rosa Rosario; Hylde Zirpoli; Kurt M Bohren; Kenneth H Gabbay; Ravichandran Ramasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

2.  Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment.

Authors:  Anna E Wentz; D André d'Avignon; Mary L Weber; David G Cotter; Jason M Doherty; Robnet Kerns; Rakesh Nagarajan; Naveen Reddy; Nandakumar Sambandam; Peter A Crawford
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

3.  Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.

Authors:  David G Cotter; Rebecca C Schugar; Anna E Wentz; D André d'Avignon; Peter A Crawford
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-11       Impact factor: 4.310

Review 4.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

Review 5.  Animal Models of Dysregulated Cardiac Metabolism.

Authors:  Heiko Bugger; Nikole J Byrne; E Dale Abel
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 6.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

7.  The Failing Heart Relies on Ketone Bodies as a Fuel.

Authors:  Gregory Aubert; Ola J Martin; Julie L Horton; Ling Lai; Rick B Vega; Teresa C Leone; Timothy Koves; Stephen J Gardell; Marcus Krüger; Charles L Hoppel; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Daniel P Kelly
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

8.  The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.

Authors:  David T Hughes; Peter M Martel; William B Kinlaw; Burton L Eisenberg
Journal:  Cancer Invest       Date:  2008-03       Impact factor: 2.176

9.  Protective effect of pregabalin on the brain tissue of diabetic rats.

Authors:  Caner F Demir; Metin Balduz; İrem Taşcı; Tuncay Kuloğlu
Journal:  Diabetol Int       Date:  2020-11-16

Review 10.  Metabolic Complications in Cardiac Aging.

Authors:  Thomas Sithara; Konstantinos Drosatos
Journal:  Front Physiol       Date:  2021-04-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.